Log In
BCIQ
Print this Print this
 

flupirtine (CNSB015)

  Manage Alerts
Collapse Summary General Information
Company Relevare Pharmaceuticals Ltd.
DescriptionCombination of the potassium channel opener flupirtine with an opioid drug
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat cancer pain; Treat neuropathic pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today